Neal Navani, Alexander van Doornewaard, Verena Schneider, Phoebe Marson Smith, Riyaz Shah, Alastair Greystoke, Matthew Krebs, Sophie Scott, Iris Faull, Elisabeth Adams, Sanjay Popat
{"title":"119 估算将ctDNA新一代测序引入晚期肺癌诊断途径的健康益处:建模研究","authors":"Neal Navani, Alexander van Doornewaard, Verena Schneider, Phoebe Marson Smith, Riyaz Shah, Alastair Greystoke, Matthew Krebs, Sophie Scott, Iris Faull, Elisabeth Adams, Sanjay Popat","doi":"10.1016/j.lungcan.2024.107680","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":507097,"journal":{"name":"Lung cancer","volume":"379 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"119 Estimating the health benefits of introducing ctDNA next generation sequencing to the diagnostic pathway for advanced lung cancer: A modelling study\",\"authors\":\"Neal Navani, Alexander van Doornewaard, Verena Schneider, Phoebe Marson Smith, Riyaz Shah, Alastair Greystoke, Matthew Krebs, Sophie Scott, Iris Faull, Elisabeth Adams, Sanjay Popat\",\"doi\":\"10.1016/j.lungcan.2024.107680\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":507097,\"journal\":{\"name\":\"Lung cancer\",\"volume\":\"379 \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lung cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.lungcan.2024.107680\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lung cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.lungcan.2024.107680","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
119 Estimating the health benefits of introducing ctDNA next generation sequencing to the diagnostic pathway for advanced lung cancer: A modelling study